DUR system likely to be further promoted

With belated move of the Korea Food and Drug Administration to ban 75 companies from producing and selling 167 products containing phenylpropanolamine (PPA), there is a social consensus on safer use of drugs and this mood is expected to further promote the drug utilization review (DUR) system.

The government and the ruling Uri Party pledged to implement the re-classification of drugs and mor...